Genistein mechanisms and timing of prostate cancer chemoprevention in Lobund-Wistar rats

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 1, 2009, Pages 143-150

  Wang, Jun ^a   Eltoum, Isam Eldin ^b,c   Carpenter, Mark ^d   Lamartiniere, Coral A ^a,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d AUBURN UNIVERSITY   (United States)

Author keywords

Chemoprevention; Genistein; Prostate cancer; Rat model

Indexed keywords

EID: 67650911933     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Adlercreutz H, (1995). Phytoestrogens: epidemiology and a possible role in cancer protection. Env Health Persp, 103, 103-112.
2. Adlercreutz H, Fotsis T, Bannwart C, et al, (1991). Isotope dilution gas chromatographic-mass spectrometric method for the determination of lignans and isoflavonoids in human urine, including identification of genistein. Clinica Chimica Acta, 199, 263-78.
3. Adlercreutz H, Markkanen H, Watanabe S, (1993). Plasma concentrations of phyto-estrogens in Japanese men. Lancet, 342, 1209-10.
4. Akiyama T, Ishida J, Nakagawa S, et al, (1987). A specific inhibitor of tyrosine-specific protein kinases. J Biol Chem, 262, 5592-5.
5. Barnes S, Lamartiniere CA, (2003). The role of phytoestrogens as cancer prevention agents. In 'Cancer Chemoprevention', Humana Press Inc., Totowa, pp. 359-369.
6. Bosland MC, Prinsen MK, (1990). Induction of dorsolateral prostate adenocarcinomas and other accessory sex gland lesions in male Wistar rats by a single administration of Nmethyl-N nitrosourea, 7,12- dimethylbenz[a]-anthracene, and 3,2'- dimethyl-4-amino-biphenyldimethyl-4-aminobiphenyl after sequential treatment with cyproterone acetate and testosterone propionate. Cancer Res, 50, 691-9.
7. Brunet A, Bonni A, Zigmond MJ, et al, (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96, 857-68.
8. Burgering BM, Coffer PJ, (1995). Protein, kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature, 376, 599-602.
9. Cao F, Jin TY, Zhou YF, (2006). Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene. Biomed Environ Sci, 19, 35-41.
10. Cardone MH, Roy N, Stennicke HR, et al, (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318-21.
11. Constantinou A, Huberman E, (1995). Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc Soc Exp Biol Med, 208, 109-15.
12. Cook LS, Goldoft M, Schwartz SM, et al, (1999). Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol, 161, 152-5.
13. Culig Z, (2003). Role of the androgen receptor axis in prostate cancer. Urology, 62 (S 5A), 21-6.
14. Dalu A, Haskell JF, Coward L, et al, (1998). Genistein, a component of soy, inhibits the expression of the EGF and ErbB/Neu receptors in the rat dorsolateral prostate. Prostate, 37, 36-43.
15. Datta SR, Dudek H, Tao X, et al, (1997). Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery. Cell, 91, 231-41.
16. Davies MA, Koul D, Dhesi H, et al, (1999). Regulation of Akt/ PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res, 59, 2551-6.
17. Davis JN, Singh B, Bhuiyan M, et al, (1998). Genistein- induced upregulation of p21WAF1, downregulation of cyclinB, and induction of apoptosis in prostate cancer cells. Nutr Cancer, 32, 123-31.
18. Denmeade SR, Lin XS, Isaacs JT, (1996). Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate, 28, 251-65.
19. Depowski PL, Rosenthal SI, Ross JS, (2001). Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod Pathol, 14, 672-6.
20. Dupont J, Renou JP, Shani M, et al, (2002). PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium. J Clin Inv, 110, 815-25.
21. Fotsis T, Pepper M, Adlercreutz H, et al, (1993). Genistein, a dietary derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA, 90, 2690-4.
22. Franke TF, Yang SI, Chan TO, et al, (1995). The protein kinase encoded by the Akt proto-oncogene is a target of the PDGFactivate phosphatidylinositol 3-kinase. Cell, 81, 727-36.
23. Franke TF, Kaplan DR, Cantley LC, (1997). PI3K: downstream AKTion blocks apoptosis. Cell, 88, 435-7.
24. Fritz WA, Coward L, Wang J, et al, (1998). Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis, 19, 2151-8.
25. Fritz WA, Wang J, Eltoum IE, et al, (2002). Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol Cell Endo, 186, 89-99.
26. Hu Z, Ito T, Yuri K, et al, (1998). In vivo time course of morphological changes and DNA degradation during the degeneration of castration-induced apoptotic prostate cells. Cell Tissue Res, 294, 153-60.
27. Lamartiniere CA, Cotroneo MS, Fritz WA, et al, (2002). Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr, 132, 552S-8S.
28. Li J, Yen C, Lia, D, et al, (1997). PTEN, a putative tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-7.
29. Li P, Nicosia SV, Bai W, (2001). Antagonism between PTEN/MMAC1/TEP-1 and androgen receptor in growth and apoptosis of prostatic cancer cells. J Biol Chem, 276, 20444-50.
30. Li Y, Upadhyay S, Bhuiyan M, et al, (1999). Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene, 18, 3166-72.
31. Li Y, Sarkar FH, (2002). Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res, 8, 2369-77.
32. Morton MS, Chan PS, Cheng C, et al, (1997). Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate, 32, 122-8.
33. Nan B, Snabboon T, Unni E, et al, (2003). The PTEN tumor suppressor is a negative modulator of androgen receptor transcriptional activity. J Mol End, 31, 169-83.
34. Pagliacci MC, Smacchia M, Migliorati G, et al, (1994). Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer, 30A, 1675-82.
35. Pollard M, (1973). Spontaneous prostate adenocarcinomas in aged germ free Wistar rats. J Natl Cancer Inst, 51, 1235-41.
36. Pollard M, Luckert PH, (1986). Production of autochthonous prostate cancer on L-W rats by treatments with N-nitroso-N-methylurea and testosterone. J Natl Cancer Inst, 77, 583-7.
37. Pollard M, (1998). Lobund-Wistar rat model of prostate cancer in man. Prostate, 37, 1-4.
38. Price D, (1963). Comparative aspects of development and structures in the prostate. Natl Cancer Inst Monogr, 12, 1-18.
39. Prins GS, Birch L, (1993). Immunocytochemical analysis of androgen receptor along the ducts of the separate rat prostate lobes after androgen withdrawal and replacement. Endocrinology, 132, 169-78.
40. Reed JC, (1999). Mechanisms of apoptosis avoidance in cancer. Curr Opin Oncol, 11, 68-75.
41. Shimizu H, Ross RK, Bernstein L, et al, (1991). Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer, 63, 963-6.
42. Stiles B, Groszer M, Wang S, et al, (2004). PTENless means more. Dev Biol, 273, 175-84.
43. Stambolic V, Suzuki A, de la Pompa JL et al, (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 95, 29-39.
44. Sharma M, Chuang WW, Sun Z, (2002). Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3 inhibition and nuclear β-catenin accumulation. J Biol Chem, 277, 30935-41.
45. Schleicher RL, Fallon MT, Austin G, et al, (1996). Intravenous vs. intraprostatic administration of N-methy-N-nitrosourea to induce prostate cancer in rats. Prostate, 28, 32-43.
46. Shu XO, Jin F, Dai Q, et al, (2001). Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev, 10, 483-8.
47. Simpson L, Parsons R, (2001). PTEN: Life as a tumor suppressor. Exp Cell Res, 264, 29-41.
48. Wang J, Eltoum IE, Lamarteniere CA, (2002). Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats. Cancer Lett, 186, 11-8.
49. Wechter WJ, Leipold DD, Murray ED, et al, (2000). E-7869 (Rflurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. Cancer Res, 60, 2203-8.
50. Wei H, Bowen R, Cai Q, et al, (1995). Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med, 208, 124-130.
51. Weng LP, Smith WM, Dahia PLM, et al, (1999). PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Cancer Res, 59, 5808-14.
52. Yuan XJ, Wang YE, (2002). PTEN sensitizes prostate cancer cells to death receptor-mediated and drug- induced apoptosis through a FADD-dependent pathway. Oncogene, 21, 319-27.